Aselage Steve (CIK 0001221599)

Latest company ownership

Shares held
146,919
Last filed at
May 12, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4
Shares held
39,072
Last filed at
Jun 15, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 24, 2024 May 29, 2024 BIOCRYST PHARMACEUTICALS INC Director Buy 83.8 +2,500 3.95% ✗ $16K
May 11, 2022 May 12, 2022 Travere Therapeutics, Inc. Director Sell 42.5 -2,575 -1.72% ✗ $56.5K
Nov 16, 2021 Nov 18, 2021 Travere Therapeutics, Inc. Director Sell 17.5 -31,800 -17.54% ✓ $934.6K
Nov 5, 2021 Nov 9, 2021 Travere Therapeutics, Inc. Director Sell 30.0 -10,000 -5.23% ✓ $262.3K
Feb 4, 2021 Nov 3, 2021 Travere Therapeutics, Inc. Director Sell 35.0 -8,500 -4.48% ✓ $252.4K
Oct 7, 2021 Oct 8, 2021 Travere Therapeutics, Inc. Director Sell 10.0 -60,000 -24.02% ✓ $1.6M
May 11, 2021 May 13, 2021 Travere Therapeutics, Inc. Director Sell 46.3 -2,146 -1.14% ✗ $42K
Apr 16, 2021 Apr 20, 2021 Travere Therapeutics, Inc. Director Sell 30.0 -10,000 -5.03% ✓ $262.3K
Mar 17, 2021 Mar 19, 2021 Travere Therapeutics, Inc. Director Sell 26.3 -17,727 -8.58% ✓ $486.5K
Feb 2, 2021 Feb 2, 2021 Travere Therapeutics, Inc. Director Sell 22.5 -25,000 -11.28% ✓ $768.8K
Dec 15, 2020 Dec 16, 2020 Travere Therapeutics, Inc. Director Sell 22.5 -5,549 -2.74% ✗ $144.4K
Nov 19, 2020 Dec 4, 2020 Travere Therapeutics, Inc. Director Sell 22.5 -10,891 -5.11% ✗ $184.8K
Nov 5, 2020 Nov 6, 2020 Travere Therapeutics, Inc. Director Sell 26.3 -23,125 -9.79% ✓ $527.5K
Aug 5, 2020 Aug 6, 2020 Travere Therapeutics, Inc. Director Sell 48.8 -2,500 -1.05% ✓ $49.2K
Jun 25, 2020 Jun 29, 2020 Travere Therapeutics, Inc. Director Sell 37.5 -10,000 -4.02% ✓ $200K
May 12, 2020 May 14, 2020 Travere Therapeutics, Inc. Director Sell 37.5 -8,125 -3.20% ✓ $130K
May 5, 2020 May 6, 2020 Travere Therapeutics, Inc. Director Sell 51.3 -2,500 -0.98% ✓ $39.7K
Mar 5, 2020 Mar 9, 2020 Travere Therapeutics, Inc. Director Sell 87.5 +7,891 3.18% ✗ $66.9K
Feb 5, 2020 Feb 7, 2020 Travere Therapeutics, Inc. Director Sell 51.3 -2,500 -1.00% ✓ $41.6K
Nov 29, 2019 Nov 29, 2019 Travere Therapeutics, Inc. Director Sell 22.5 -5,000 -1.95% ✗ $69.6K
Nov 18, 2019 Nov 18, 2019 BIOCRYST PHARMACEUTICALS INC Director Buy 91.3 +15,000 224.82% ✗ $21.8K
May 22, 2019 May 24, 2019 BIOCRYST PHARMACEUTICALS INC Director Buy 91.3 +3,000 150.00% ✗ $10.7K
May 14, 2019 May 16, 2019 Travere Therapeutics, Inc. Director Sell 45.0 -3,676 -1.42% ✓ $65.5K
Mar 12, 2019 Mar 14, 2019 BIOCRYST PHARMACEUTICALS INC Director Buy 91.3 +2,000 100.00% ✗ $16.6K
Feb 11, 2019 Feb 13, 2019 Travere Therapeutics, Inc. CEO Sell 51.3 -2,130 -0.82% ✓ $45.7K
Dec 20, 2018 Dec 21, 2018 Travere Therapeutics, Inc. CEO Sell 35.0 -12,376 -4.55% ✓ $270.8K
Nov 29, 2018 Dec 7, 2018 Travere Therapeutics, Inc. CEO Sell 37.5 -1,760 -0.69% ✗ $240.4
Nov 14, 2018 Nov 16, 2018 Travere Therapeutics, Inc. CEO Sell 35.0 -11,100 -4.20% ✓ $266.7K
Aug 31, 2018 Aug 31, 2018 Travere Therapeutics, Inc. CEO Sell 35.0 -12,000 -4.65% ✓ $384K
Jun 14, 2017 Jun 14, 2017 Travere Therapeutics, Inc. CEO Sell 22.5 -5,000 -2.00% ✗ $89.3K
Nov 21, 2016 Nov 23, 2016 Travere Therapeutics, Inc. CEO Sell 22.5 -65,200 -21.32% ✗ $173.2K
Nov 9, 2015 Nov 12, 2015 Travere Therapeutics, Inc. CEO Sell 15.0 -60,000 -16.27% ✓ $1.1M
Nov 20, 2014 Nov 21, 2014 Travere Therapeutics, Inc. CEO Buy 87.5 +10,000 2.76% ✗ $84.6K
Aug 15, 2013 Dec 27, 2013 Travere Therapeutics, Inc. Director Buy 60.0 +556 0.21% ✗ $2.5K